Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer

Journal of Clinical Microbiology

Volumn 44, Issue 5, 2006, Pages 1755-1762

  Arias Pulido, Hugo ^a   Peyton, Cheri L ^a,d   Joste, Nancy E ^a   Vargas, Hernan ^b,c   Wheeler, Cosette M ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c Instituto Nacional de Cancerología   (Colombia)

^d OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; PARAFFIN; VIRUS DNA;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EPISOME; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; INVASIVE CARCINOMA; MICRODISSECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME;

BASE SEQUENCE; CELL LINE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOME MAPPING; DNA PRIMERS; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; GENES, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PLASMIDS; POLYMERASE CHAIN REACTION; SEQUENCE DELETION; SEQUENCE HOMOLOGY, NUCLEIC ACID; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33646596267     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.5.1755-1762.2006     Document Type: Article

References (42)

1. Arias-Pulido, H., N. Joste, and C. Wheeler. 2004. Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype. Genes Chromosomes Cancer 40:277-284.
2. Berumen, J., E. Unger, L. Casas, and P. Figueroa. 1995. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum. Pathol. 26:676-681.
3. Corpet, F. 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16:10881-10890.
4. Daniel, B., A. Rangarajan, G. Mukherjee, E. Vallikad, and S. Krishna. 1997. The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J. Gen. Virol. 78:1095-1101.
5. Fink, L., W. Seeger, L. Ermert, J. Hanze, U. Stahl, F. Grimminger, W. Kummer, and R. M. Bohle. 1998. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat. Med. 4:1329-1333.
6. Fontaine, J., C. Hankins, M. Mayrand, J. Lefevre, D. Money, S. Gagnon, A. Rachlis, K. Pourreaux, A. Ferenczy, and F. Coutlee. 2005. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS 19:785-794.
7. Gallo, G., M. Bibbo, L. Bagella, A. Zamparelli, F. Sanseverino, M. R. Giovagnoli, A. Vecchione, and A. Giordano. 2003. Study of viral integration of HPV-16 in young patients with LSIL. J. Clin. Pathol. 56:532-536.
8. Graham, D. A., and C. S. Herrington. 2000. HPV-16 E2 gene disruption and sequence variation in CIN 3 lesions and invasive squamous cell carcinomas of the cervix: relation to numerical chromosome abnormalities. Mol. Pathol. 53:201-206.
9. Gravitt, P., C. Peyton, C. Wheeler, R. Apple, R. Higuchi, and K. Shah. 2003. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J. Virol. Methods 112:23-33.
10. Hopman, A., F. Smedts, W. Dignef, M. Ummelen, G. Sonke, M. Mravunac, G. Vooijs, E. Speel, and F. Ramaekers. 2004. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J. Pathol. 202:23-33.
11. Hudelist, G., M. Manavi, K. I. D. Pischinger, T. Watkins-Riedel, C. F. Singer, E. Kubista, and K. F. Czerwenka. 2004. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol. Oncol. 92:873-880.
12. Jemal, A., R. C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, E. Ward, E. J. Feuer, and M. J. Thun. 2004. Cancer statistics. 2004. CA Cancer J. Clin. 54:8-29.
13. Jeon, S., B. Allen-Hoffmann, and P. Lambert. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:2989-2997.
14. Jeon, S., and P. Lambert. 1995. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc. Natl. Acad. Sci. USA 92:1654-1658.
15. Kalantari, M., E. Blennow, B. Hagmar, and B. Johansson. 2001. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn. Mol. Pathol. 10:46-54.
16. Kalantari, M., F. Karlsen, G. Kristensen, R. Holm, B. Hagmar, and B. Johansson. 1998. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int. J. Gynecol. Pathol. 17:146-153.
17. Klaes, R., S. M. Woerner, R. Ridder, N. Wentzensen, M. Duerst, A. Schneider, B. Lotz, P. Melsheimer, and M. V. K. Doeberitz. 1999. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 59:6132-6136.
18. Luft, F., R. Klaes, M. Nees, M. Durst, V. Heilmann, P. Melsheimer, and M. von Knebel Doeberitz. 2001. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int. J. Cancer 92:9-17.
19. Meissner, J. 1999. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J. Gen. Virol. 80:1725-1733.
20. Meissner, J. 1997. Sequencing errors in reference HPV clones, p. III-110-III-123. In G. Myers, C. Baker, K. Munger, F. Sverdup, A. McBride, H.-U. Bernard, and J. Meissner (ed.). Human papillomaviruses 1997: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical biology and biophysics. Los Alamos National Laboratory, Los Alamos, N.M.
21. Melnikow, J., J. Nuovo, A. Willan, B. Chan, and L. Howell. 1998. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet. Gynecol. 92:727-735.
22. Myers, G., H.-U. Bernard, H. Delius, C. Baker, J. Icenogle, A. Halpern, and C. Wheeler. 1995. Human papillomavirus. A compilation and analysis of nucleic acid and amino acid sequences. Publication LA-UR 95-3675. Los Alamos National Laboratory, Los Alamos, N.M.
23. Nagao, S., M. Yoshinouchi, Y. Miyagi, A. Kongo, J. Kodama, S. Itoh, and T. Kudo. 2002. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J. Clin. Microbiol. 40:863-867.
24. Peitsaro, P., B. Johansson, and S. Syrjanen. 2002. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 40:886-891.
25. 24a. Pett, M. R., M. T. Herdman, R. D. Palmer, G. S. H. Yeo, M. K. Shivji, M. A. Stanley, and N. Coleman. 2006. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc. Natl. Acad. Sci. USA 103:3822-3827.
26. Peyton, C., P. Gravitt, W. Hunt, R. Hundley, M. Zhao, R. Apple, and C. Wheeler. 2001. Determinants of genital human papillomavirus detection in a US population. J. Infect. Dis. 183:1554-1564.
27. Pulido, H. A., M. J. Fakruddin, A. Chatterjee, E. D. Esplin, N. Beleno, G. Martinez, H. Posso, G. A. Evans, and V. V. V. S. Murty. 2000. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. Cancer Res. 60:6677-6682.
28. Romanczuk, H., and P. Howley. 1992. Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc. Natl. Acad. Sci. USA 89:3159-3163.
29. Sherman, M. E., S. S. Wang, C. M. Wheeler, L. Rich, P. E. Gravitt, R. Tarone, and M. Schiffman. 2003. Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. Cancer Epidemiol. Biomarkers Prev. 12:1038-1044.
30. Stevenson, M., L. C. Hudson, J. E. Burns, R. L. Stewart, M. Wells, and N. J. Maitland. 2000. Inverse relationship between the expression of the human papillomavirus type 16 transcription factor E2 and virus DNA copy number during the progression of cervical intraepithelial neoplasia. J. Gen. Virol. 81:1825-1832.
31. Stoler, M. 2000. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int. J. Gynecol. Pathol. 19:16-28.
32. Terry, G., L. Ho, and J. Cuzick. 1997. Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type. Int. J. Cancer 73:651-655.
33. Tonon, S., M. Picconi, P. Bos, J. Zinovich, J. Galuppo, L. Alonio, and A. Teyssie. 2001. Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. J. Clin. Virol. 21:129-134.
34. Tornesello, M. L., F. M. Buonaguro, L. Buonaguro, I. Salatiello, E. Beth-Giraldo, and G. Giraldo. 2000. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J. Gen. Virol. 81:2969-2982.
35. Ueda, Y., T. Enomoto, T. Miyatake, K, Ozaki, T. Yoshizaki, H. Kanao, Y. Ueno, R. Nakashima, K. Shroyer, and Y. Murata. 2003. Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia. Lab. Investig. 83:1517-1527.
36. Unger, E., S. Vernon, W. Thorns, R. Nisenbaum, C. Spann, I. Horowitz, J. Icenogle, and W. Reeves. 1995. Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer. J. Infect. Dis. 172:1184-1190.
37. Vernon, S., E. Unger, D. Miller, D. Lee, and W. Reeves. 1997. Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int. J. Cancer 74:50-56.
38. Vizcaino, A., V. Moreno, F. Bosch, N. Munoz, X. Barros-Dios, J. Borras, and D. Parkin. 2000. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int. J. Cancer 86:429-435.
39. Wentzensen, N., S. Vinokurova, and M. V. K. Doeberitz. 2004. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res. 64:3878-3884.
40. World Health Organization. 2005. IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 90. Human papillomaviruses. International Agency for Research on Cancer, Lyon, France.
41. Yoshinouchi, M., A. Hongo, K. Nakamura, J. Kodama, S. Itoh, H. Sakai, and T. Kudo. 1999. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancer. J. Clin. Microbiol. 37:3514-3517.
42. Ziegert, C., N. Wentzensen, S. Vinokurova, F. Kisseljov, J. Einenkel, M. Hoeckel, and M. von Knebel Doeberitz. 2003. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 22:3977-3984.